25 September, 2020
The regulatory approval and commercialisation of Luxturna in 2017 has opened the floodgates for gene therapy, with numerous clinical trials underway or rapidly approaching. Dr Tom Edwards and Dr Lauren Ayton will update Retina Australia members on the national approach to identifying and characterising people who might be eligible for these trials (through the Inherited Retinal Disease Natural History Study), as well as describing the most promising developments in the field.
This webinar will take place on Saturday 17th October at 2:00pm EST. You can find a copy of the flyer in Word version here or in PDF version here
https://retinaaustralia.com.au/webinar-event-gene-therapy-clinical-trials-and-new-developments-in-ird-research/
Other News
2024 Research Grants Announced
Retina Australia is delighted to announce two new Research Grant recipients for 2024. The new projects will focus on Stargardt disease and Virtual Reality...
Retina Australia’s website upgraded, rebranded and accessibility compliant
Retina's Australia's new website is now live, upgraded for...
2023 Research Grants Announced
Retina Australia is delighted to announce the Research Grant Recipients for 2023. This year, Retina Australia has provided over $115,000 in funding to two...